XyloCor Therapeutics, Inc. logo

XyloCor Therapeutics, Inc. Employee Directory

Research ServicesPennsylvania, United States11-50 Employees

XyloCor Therapeutics, Inc. is a development-stage biotechnology company in the research services industry focused on developing first-in-class gene therapies for cardiovascular disease. The company is based in King of Prussia, Pennsylvania, at 411 Swedeland Road Suite 23-1080. It employs 11-50 people. In its recent history, John Tucker was appointed President and Chief Executive Officer in March 2026, and Rachel Mears joined the Board of Directors in January 2025. The company has pursued financing activities, including a Series B in January 2025 to support its cardiovascular gene therapy programs. The organization maintains a website at https://xylocor.com.

Find XyloCor Therapeutics, Inc. employees' phone numbers or email addresses

XyloCor Therapeutics, Inc. Global Highlights

Location
Employees

North America
19

Minus sign iconPlus sign icon
  • United States Of America
    19

XyloCor Therapeutics, Inc.'s Leadership

  • Chief Medical Officer at XyloCor Therapeutics, Inc.
    E. D.
    Chief Medical Officer
  • Member Board Of Directors at XyloCor Therapeutics, Inc.
    A. C.
    Member Board Of Directors
  • Vp, Head Of Technical Operations And Cmc at XyloCor Therapeutics, Inc.
    N. G.
    Vp, Head Of Technical Operations And Cmc
  • Director Of Finance And Operations at XyloCor Therapeutics, Inc.
    J. A.
    Director Of Finance And Operations

XyloCor Therapeutics, Inc. Employee Metrics

100%
50%
0%
2026
2025
  • Entrepreneurship
  • Business
  • Analytics
  • Community & Social Services
  • Consultant
  • Other

Contact profiles from XyloCor Therapeutics, Inc.

Name
Title
Contact
Location
Last Update
  • Member Board Of Directors at XyloCor Therapeutics, Inc.
    A. C.
    Member Board Of Directors
    Bay
    Sep 15, 2026
  • Chief Medical Officer at XyloCor Therapeutics, Inc.
    E. D.
    Chief Medical Officer
    Bay
    May 22, 2026
  • Vp, Head Of Technical Operations And Cmc at XyloCor Therapeutics, Inc.
    N. G.
    Vp, Head Of Technical Operations And Cmc
    Mar 24, 2026
  • Director Of Finance And Operations at XyloCor Therapeutics, Inc.
    J. A.
    Director Of Finance And Operations
    Oct 18, 2024

Frequently Asked Questions

What is XyloCor Therapeutics, Inc. known for?

Minus sign iconPlus sign icon
XyloCor Therapeutics, Inc. was founded in 2013 and operates in the Research Services industry. Explore XyloCor Therapeutics, Inc.'s company overview page for more information.

What is XyloCor Therapeutics, Inc.'s most common email format?

Minus sign iconPlus sign icon
XyloCor Therapeutics, Inc. employees' email format typically follows the pattern of First.Last@xylocor.com. Trying to find reliable and up-to-date employee contact data? Find more XyloCor Therapeutics, Inc. email formats with LeadIQ.

How many employees does XyloCor Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
XyloCor Therapeutics, Inc. has approximately 19 employees as of August 2026. These team members are located across 1 continents, including North America.

Who are XyloCor Therapeutics, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, XyloCor Therapeutics, Inc.'s key employees include:

  • Chief Medical Officer: E. D.
  • Member Board Of Directors: A. C.
  • Vp, Head Of Technical Operations And Cmc: N. G.
  • Director Of Finance And Operations: J. A.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.